Lipocine Inc
NASDAQ:LPCN
Lipocine Inc
NASDAQ:LPCN
Price:
2.21
USD
0.91%
Market Closed
Market Cap:
$18.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Lipocine Inc
NASDAQ:LPCN
|
US |
|
Svenska Handelsbanken AB
OTC:SVNLY
|
SE |
|
Gap Inc
NYSE:GAP
|
US |
|
Telefonaktiebolaget LM Ericsson
STO:ERIC B
|
SE |
|
C
|
CVS Health Corp
DUS:CVS
|
US |
|
G
|
Gorilla Technology Group Inc
NASDAQ:GRRR
|
KY |
|
F
|
Fresenius SE & Co KGaA
DUS:FRE
|
DE |
|
Power Grid Corporation of India Ltd
NSE:POWERGRID
|
IN |
|
Lineage Inc
NASDAQ:LINE
|
US |
|
A
|
Aboitiz Power Corp
XPHS:AP
|
PH |
|
Franchise Group Inc
F:3HC
|
US |
|
Petronas Chemicals Group Bhd
OTC:PECGF
|
MY |
|
Indraprastha Gas Ltd
NSE:IGL
|
IN |
|
G
|
GeoPark Ltd
NYSE:GPRK
|
CO |
|
Arcadis NV
AEX:ARCAD
|
NL |
Wall St Price Targets
LPCN Price Targets Summary
Lipocine Inc
Lipocine Inc
Wall Street analysts forecast LPCN stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for LPCN is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.
Lowest Forecast
Price Target
6.06
USD
174% Upside
Average Forecast
Price Target
6.12
USD
177% Upside
Highest Forecast
Price Target
6.3
USD
185% Upside
Lipocine Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LPCN's stock price target?
Price Target
6.12
USD
6.12
USD
According to Wall Street analysts, the average 1-year price target for LPCN is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.
What is the Revenue forecast for Lipocine Inc?
Projected CAGR
112%
112%
The compound annual growth rate for Revenue over the next 5 years is 112%.
